A detailed history of Childress Capital Advisors, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Childress Capital Advisors, LLC holds 1,429 shares of TMO stock, worth $716,343. This represents 0.24% of its overall portfolio holdings.

Number of Shares
1,429
Previous 1,436 0.49%
Holding current value
$716,343
Previous $794,000 11.21%
% of portfolio
0.24%
Previous 0.23%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$531.86 - $624.21 $3,723 - $4,369
-7 Reduced 0.49%
1,429 $883,000
Q2 2024

Aug 05, 2024

BUY
$541.52 - $599.02 $777,622 - $860,192
1,436 New
1,436 $794,000
Q4 2023

Feb 16, 2024

SELL
$431.41 - $532.94 $83,262 - $102,857
-193 Reduced 11.54%
1,479 $785,000
Q3 2023

Nov 06, 2023

BUY
$498.29 - $574.41 $833,140 - $960,413
1,672 New
1,672 $846,000
Q4 2022

Feb 03, 2023

SELL
$484.71 - $571.37 $173,041 - $203,979
-357 Reduced 16.62%
1,791 $986,000
Q3 2022

Nov 03, 2022

BUY
$507.19 - $604.49 $11,158 - $13,298
22 Added 1.03%
2,148 $1.1 Million
Q2 2022

Aug 15, 2022

BUY
$500.9 - $612.21 $74,133 - $90,607
148 Added 7.48%
2,126 $1.16 Million
Q1 2022

May 10, 2022

BUY
$524.0 - $644.92 $86,984 - $107,056
166 Added 9.16%
1,978 $1.17 Million
Q4 2021

Jan 26, 2022

SELL
$569.0 - $667.24 $10,242 - $12,010
-18 Reduced 0.98%
1,812 $1.21 Million
Q3 2021

Nov 15, 2021

BUY
$509.53 - $609.78 $112,606 - $134,761
221 Added 13.74%
1,830 $1.05 Million
Q2 2021

Jul 28, 2021

SELL
$441.0 - $508.24 $10,584 - $12,197
-24 Reduced 1.47%
1,609 $811,000
Q1 2021

May 21, 2021

BUY
$439.85 - $518.83 $151,748 - $178,996
345 Added 26.79%
1,633 $745,000
Q4 2020

Mar 09, 2021

BUY
$435.06 - $527.66 $560,357 - $679,626
1,288 New
1,288 $600,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $196B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Childress Capital Advisors, LLC Portfolio

Follow Childress Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Childress Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Childress Capital Advisors, LLC with notifications on news.